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Introduction.– Le stiff-knee est un défaut de raccourcissement du membre
inférieur à la marche, secondaire à un défaut de flexion du genou lors de la phase
oscillante. C’est une situation clinique fréquente, notamment chez l’hémiplé-
gique, qui a fait l’objet de nombreux travaux dans la littérature. Il n’existe
cependant pas de consensus sur la démarche diagnostique et thérapeutique.
Nous proposons un arbre décisionnel diagnostique et thérapeutique développé à
partir des données de la littérature et de l’expérience du service de MPR du
CHU de Toulouse.
Mate´riel et me´thode.– Certains éléments cliniques clés doivent être relevés, tels
que la force du quadriceps, des fléchisseurs de hanche et du genou et du triceps
sural. La spasticité du quadriceps doit être analysée hanche fléchie et tendue
(droit fémoral). La compensation d’un déficit du psoas par le droit fémoral en
tant que fléchisseur de hanche doit être identifiée. Un trouble proprioceptif
éventuel doit être éliminé. Enfin, la vitesse de marche du sujet, la présence d’un
equin dynamique ou d’un recurvatum de genou doivent être intégrés au
raisonnement. L’approche clinique peut être complétée par la réalisation de
blocs moteurs sélectifs ou d’une analyse quantifiée de la marche pour préciser la
physiopathologie du stiff-knee, et orienter le traitement.
Re´sultats.– L’attitude thérapeutique découle des mécanismes physiopatholo-
giques identifiés. La kinésithérapie est indiquée, notamment pour effectuer un
travail sur le schéma de marche de manière spécifique et intensive après
injections de toxine botulique. Les injections de toxine botulique ne sont pas
systématiques, et concernent le droit fémoral et/ou les vastes. Un défaut de
raccourcissement distal en phase oscillante (equin) ou des anomalies en phase
d’appui (equin, recurvatum de genou) doivent être pris en charge de manière
concomitante afin d’optimiser l’amélioration du schéma de marche.
Conclusion.– Cet arbre décisionnel diagnostique et thérapeutique sera soumis à
un comité d’experts et évalué de fac¸on prospective pour juger de sa validité.
http://dx.doi.org/10.1016/j.rehab.2012.07.856
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Objective.– We estimated the effects of the botulinum toxin A in a population of
adult patients with cerebral palsy and spastic tetraparesia. For these patients, the
objectives were to improve comfort, posture possibilities, hygiene, and pain
relief.
Method.– A population of 20 adult cerebral palsy patients with poor spasticity
control despite combination therapy using maximal dose lioresal and either
dantrolene or valium were treated by botulinum toxin at the main joint
limitations. The most frequent limitations of these patients were in decreasingorder: permanent wrist flexion, permanent knee flexion, permanent elbow
flexion, shoulder hypoabduction, permanent hip flexion, candlestick shoulders,
thigh adduction, and claw hands.
Results.– The average age of our patients was 39.5 years, their weight was
42.4 kg, and the M/F sex ratio was 14/6. Aetiologies of cerebral palsy were
perinatal anoxia (n = 6), post-infectious encephalitis (n = 4), sequelas of
prematurity (n = 3), undetermined cause (n = 3), epileptic encephalopathia
(n = 2), Reye’s syndrome (n = 1), Engelmann syndrome (n = 1). The average
Ashworth score improved from 0.62, gain in joint range of motion were as
follows: wrist flexion 44.48, knees flexion +26.58, elbow flexion +31.78,
shoulder adduction +42.88, candlestick shoulder +108.78, hip flexion +258,
thigh adduction thigh 46.58 and claw hands +568.
Discussion.– Only few studies are available on management of spasticity with
botulinum toxin in adults with cerebral palsy. We demonstrate here that despite
longstanding joint limitations, botulinum toxin can provide significant
improvement.
http://dx.doi.org/10.1016/j.rehab.2012.07.857
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Objective.– The aim of this study was to document the clinical and BoNT-A
injection profiles of adult patients suffering from upper limb spasticity (ULS) in
France.
Methods.– Patient data was collected by physicians by means of a questionnaire
on the day of a planned injection with BoNT-A for adult patients suffering from
ULS.
Results.– Data from 141 patients (58% male, 42% female), with ULS caused
mainly by acquired brain injury (stroke-infarction; 41%, stroke-hemorrhage;
19%), suffering from ULS for more than 12 months (91%) with lesions
stabilized (93%) at the start of the study were analysed. All but one patient had a
motor deficit and half had a sensory deficit. The most frequent motor
impairment was hemiparesis (75%). Evaluation was mainly using the ROM or
MAS methods (around 90%).
Three quarter of patients had previously received a BoNT-A injection and 65%
had been treated for more than 1 year. More patients received Dysport (58%)
than Botox (42%).
Overall, main target muscles injected were flexor muscles in the forearm (flexor
digitorum superficialis; 77%, flexor carpi radialis; 53%, flexor digitorum
profundus; 43%) and in the arm (brachialis; 46% and biceps brachii; 30%). The
trend was similar for both BoNT-A preparations, except Dysport was injected
more frequently in the flexor digitorum superficialis muscle (81%) than Botox
(71%).
The highest median number of injection points by muscle (n > 10 patients) was
3 for interossei dorsales (max = 6) then 2 for all the cited most frequently
injected muscles, and pectoralis major and flexor carpi ulnari.
The range of number of units injected by muscle was 10–150 units for Botox
(range total units injected: 30–350) and 25–400 units for Dysport (range total
units injected: 100–1450). The muscles with the highest median number of
units injected (n > 10 patients) were similar for both BoNT-A: pectoralis
major, biceps brachii, brachialis and flexor digitorum superficialis (50 units)
for Botox and biceps brachii (200 units), pectoralis major (155 units) then
brachialis, flexor digitorum superficialis and flexor carpi radialis (150 units)
for Dysport.
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and target the ULS patients most likely to benefit from BoNT-A treatment.
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A study was conducted to evaluate the effect of treatment on triceps surae
spasticity in hemiparetic patients using a quantitative and reproducible
parameter: the anterior-posterior path length of the center of pressure (COP).
The F-Scan system used the embedded footings to analyze the path of the COP
and the plantar pressure during walking.
COP parameters have a good repeatability in hemiparetic patients [1].
The population consisted of 10 hemiparetic patients (six left, four right), with
disturbing spasticity of the triceps surae during ambulation, able to walk alone
with or without technical assistance (FAC functional scale between 3 and 5).
After clinical examination, walking study was achieved at own speed (with or
without technical assistance), before and after an anesthesic block of the
posterior tibial nerve. The session comprised of baropodometric, spatiotempo-
ral recordings, and a videographic survey.
The main variable analyzed was the change of anterior-posterior path length of
the COP (AP) in hemiparetic side after completion of the nerve block.
According to literature, a significant decrease in the AP in paretic side compared
to the non-paretic side was found before the nerve block [2]. AP increased
significantly after completion of the nerve block (112 vs 99 mm, P = 0.03).
In conclusion, we find a significant variation of a quantitative variable of gait in
hemiparetic patients after abolition of spasticity.
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Objective.– To examine differences in complication rates between children and
adults treated by intrathecal baclofen.
Material and method.– Retrospective chart review of 73 patients (adults and
children; 88 pumps) with a diagnosis of severe spasticity requiring intrathecal
baclofen therapy.
Results.– Complication rates by category were as follows: related to human
error: 8%, related to baclofen: 11%, related to surgery: 19% and related to the
implantable device: 27%. Complications were more frequent in adults than in
children, except for complications related to surgery. The complication raterelated to the implantable device was higher in ambulatory patients. The
complication rates related to surgery and the implantable device decreased
during the course of the study.
Conclusions.– The overall complication rate observed in our series is
comparable to that reported in the literature and, in contrast with the literature,
was not higher in children than in adults. Only complications related to the
surgical procedure were slightly more common in children. Baclofen pump
implantation in children is therefore a safe procedure.
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Introduction.– The anesthetic blocks are currently in the arsenal of diagnostic
and therapeutic motor disorders associated with spasticity.
The aim of our study is to clarify the interest of the anesthetic block in patient
assessment spastic.
Patients and methods.– Twenty patients hospitalized in the physical medicine
and functional rehabilitation were selected over a period of 2 years (since
January 2010) and who received anesthetic block during their hospitalization.
These were patients aged between 13 and 72 years (mean age 43 years) with
vascular hemiplegia in 12 cases (60%), cerebral palsy in three cases (15%),
spinal cord injury in three cases (15%), head trauma in 1 case (5%) and a
hereditary disease in one case (5%).
The anesthetic blocks were performed by specific needles and a pacemaker,
respecting the location techniques. The anaesthetic used was mainly 2% non-
adrenalized etidocaine (Xylocaïne1) An analytical assessment of spasticity by
the Ashworth score and functional walking was performed for each patient.
Results.– Twenty anesthetic blocks were performed. The injected sites were
dominated by the soleus nerve (48%), the median nerve (33%) and the posterior
tibial nerve (11%).
We noted an Ashworth score gain of about 1 to 2 points, a gain of 138 joint and
an average improvement of gait in 11 patients (64%).
Fifteen patients (75%) benefited from an injection of botulinum toxin and one
patient was operated (neurotomy).
Conclusion.– The anesthetic blocks currently represent a simple and effective
approach with a dual interest in diagnosis and prognosis.
They are shown to reproduce the transient effect expected a more sustainable
and therefore more costly by providing an effective local treatment of spasticity.
http://dx.doi.org/10.1016/j.rehab.2012.07.861
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Introduction.– Primary and secondary dystonia with truncal dystonia are often
associated with spinal involvement as low-back pain. Interest of botulinum
toxin is well described in literature for cervical dystonia but less for truncal
dystonia. We report the case of a patient who received local botulinum toxin
